INVO Fertility (IVF) Liabilities and Shareholders Equity (2010 - 2026)

INVO Fertility (IVF) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $24.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 131.41% year-over-year to $24.7 million; the TTM figure through Mar 2026 stood at $83.0 million (up 45.17% YoY), while the FY2025 annual figure was $20.2 million, down 56.47% from the prior year.
• Liabilities and Shareholders Equity rose to $24.7 million in Q1 2026 per IVF's latest filing, from $20.2 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $46.4 million in Q4 2024 and bottomed at -$375355.0 in Q1 2023.
• Historically, Liabilities and Shareholders Equity has averaged $12.6 million across 5 years, with a median of $10.7 million in 2025.
• Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity plunged 104.65% — and 2025, when it jumped 42318.68%.
• INVO Fertility's Liabilities and Shareholders Equity stood at $3.7 million in 2022, then jumped by 398.84% to $18.5 million in 2023, then soared by 151.0% to $46.4 million in 2024, then sank by 56.47% to $20.2 million in 2025, then rose by 21.94% to $24.7 million in 2026.
• Business Quant data shows IVF's Liabilities and Shareholders Equity at $24.7 million in Q1 2026, $20.2 million in Q4 2025, and $18.8 million in Q3 2025.